Thymosin Beta

thymosin beta · RegeneRx Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Thymosin Beta, covering 2017-04-17 to 2017-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers [Phase 1]